OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
February 02, 2019
Leveraging vast quantities of analytical data requires digitalization and platform integration.
January 02, 2019
Orphan and cancer drugs continue to lead, but treatments for many common diseases were also approved in 2018.
December 02, 2018
Microbial identity data can be critical for determining contamination sources.
Antibody-based drugs offer new mechanisms of action and greater specificity.
November 02, 2018
Demand for highly potent APIs continues to rise.
October 02, 2018
Integration of new modeling and analytical tools with flow chemistry are notable trends.